Both groups were compared with each other from the aspect of postoperative need for intraaortic balloon counterpulsation (IABP), inotropic drug support, extubation time, length of intensive care unit and hospitalization stays, renal failure, stroke, malignant ventricular arrhythmia, atrial fibrillation, postoperative myocardial infarction and cardiac mortality.
After the operation, need for intraaortic balloon counterpulsation (IABP) or inotropic drug support, occurrence of low cardiac output syndrome (LCOS), malignant ventricular arrhythmias or atrial fibrillation, development of postoperative myocardial infarction, extubation time, length of intensive care unit (ICU) stay, neurological or renal complications, discharge time and cardiac mortality were recorded.
Nussbaum ES, Sebring LA, Ganz WE Madison MT Intraaortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: a xenon-enhanced computed tomography study.
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-1 Study.
Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery.
In-hospital complications of percutaneous intraaortic balloon counterpulsation.
The cuffs swiftly inflate at onset of diastole and rapidly deflate at onset of systole, providing hemodynamic effects similar to intraaortic balloon counterpulsation
, including increased coronary artery blood flow along with afterload reduction.